Chronological Archive · Guideline Revisions & Editorial Notes

Clinical Guideline Updates & Evidence Audit Ledger

Name: Cancer Screening Guideline Updates & Evidence Ledger (2026)
Published: 2026-10-18

Clinical Summary & Absolute Outcome Takeaway

This ledger tracks major revisions across USPSTF, ACS, NCCN, and international cancer screening guidelines - including the 2024 USPSTF age-40 mammography shift, the 2023 ACS lung cancer quit-year removal, the 2024 FDA national breast density notification rule, and ongoing multi-cancer liquid biopsy trial readouts.

Published Editions & Guideline Audits

2026-10-18 · ARCHIVAL MANIFESTO EDITORIAL DESK

Why We Rebuilt ScreeningForCancer.org as an Independent 1,000-Person Concordance Desk

Tracing the domain's 2015 Harvard Medical School citation during the USPSTF vs. ACS mammography controversy to the 2024-2026 era of age-40 breast screening, Cologuard billing rules, and commercial full-body MRI hype.

Read Full Editorial Monograph →

2026-11-06 · GUIDELINE AUDIT CORE MATRIX

2024-2026 Key Guideline Shifts: Breast Age 40, Lung Quit-Year Removal & Self-Collected HPV

Summary of the three highest-impact screening changes for primary care: USPSTF's return to age 40 biennial mammography, ACS's elimination of the 15-year smoking cessation cap for LDCT, and FDA approval of clinic-based vaginal HPV self-collection.

View Updated Multi-Society Matrix →